Risk of Myopathy Associated With DPP-4 Inhibitors in Combination With Statins: A Disproportionality Analysis Using Data From the WHO and French Spontaneous Reporting Databases

Vanessa Labat; Mickael Arnaud; Ghada Miremont-Salamé; Francesco Salvo; Bernard Bégaud; Antoine Pariente

doi:10.2337/dc16-1822

Risk of Myopathy Associated With DPP-4 Inhibitors in Combination With Statins: A Disproportionality Analysis Using Data From the WHO and French Spontaneous Reporting Databases

Diabetes Care. 2017 Mar;40(3):e27-e29. doi: 10.2337/dc16-1822. Epub 2016 Dec 20.

Authors

Vanessa Labat^{1

2}, Mickael Arnaud^{3

2}, Ghada Miremont-Salamé^{3

2

4}, Francesco Salvo^{3

2

4}, Bernard Bégaud^{2

4}, Antoine Pariente^{3

2

4}

Affiliations

¹ University of Bordeaux, Bordeaux, France labat.vanessa@yahoo.fr.
² Pharmacoepidemiology Team, Bordeaux Population Health Research Center, INSERM U1219, Bordeaux, France.
³ University of Bordeaux, Bordeaux, France.
⁴ Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

PMID: 27998912
DOI: 10.2337/dc16-1822

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't